Editorially curated · sa-kfshrc-rady-newborn-genomics
KFSHRC-Rady Genome-Based Newborn Screening Platform
Aims to implement genome-based newborn screening for approximately 500 treatable/preventable conditions while studying clinical utility, cost-effectiveness, protocols and workforce needs.
01 / Project overview
What the record establishes.
- Geographic scope
- Saudi newborns; initial deployment cohort not disclosed
- Project type
- Genome-based newborn screening implementation partnership
- Research domain
- Treatable genetic disease and implementation research
- Years
- 2025–
- Lifecycle status
- implementation
- Status basis
- Agreement and KFSHRC entry into the BeginNGS Consortium were announced on 2025-10-07; no published Saudi cohort size or outcomes are yet available.
- Status evidence date
- 2025-10-07
- Scale
- Condition scope approximately 500; participant scale not disclosed.
02 / Organizations and population
Who and what the project connects.
- Lead organizations
- King Faisal Specialist Hospital & Research Centre (KFSHRC) · Rady Children's Institute for Genomic Medicine
- Partner organizations
- BeginNGS Consortium
- Organism / population
- Saudi newborns
03 / Data and access
What exists and how it can be reached.
Data types
- newborn whole-genome sequencing
- clinical utility
- health economics
- implementation metrics
Data access
No released cohort data; clinical/controlled implementation
Identifiers
No public accession or identifier is listed for this record.
04 / Evidence and provenance
Why the record is included.
Inclusion basis
Official national-referral implementation partnership in an international genome-based newborn-screening consortium.
Editorial note
Potential future overlap with Baby Genome is unknown; there is no evidence that they are the same initiative. No enrollment should be inferred from condition count.
Sources
- primary record source Verified 2026-08-15
- additional record source Verified 2026-08-15
- additional record source Verified 2026-08-15
Release v0.2.0